Cytogel Pharma
Manufacturing · Connecticut, United States · 1-10 Employees
View Company Info for Free
Overview
Headquarters
3 Thorndal Cir, Darien, Connecticut, 068...Phone Number
(203) 662-6617Website
www.cytogelpharma.comRevenue
<$5 MillionIndustry
About Cytogel Pharma
Cytogel Pharma is a clinical stage biopharmaceutical company focused on developing first-in-class drug candidates from the novel endomorphin family of peptides to provide effective pain relief. Their lead product, CYT-1010, targets key pain pathways with a unique mechanism of action, aiming to transform the treatment of moderate to severe pain while minimizing addiction potential and respiratory depression. The company is dedicated to serving patients in pain and offers an attractive alternative to traditional opioid therapies. With a commitment to scientific evidence and clinical proof of concept, Cytogel Pharma seeks to deliver safe and effective pain management solutions.Explore more
Cytogel Pharma Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Compare Similar Companies to Cytogel Pharma
Compare insights from companies similar to Cytogel Pharma, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Cytogel Pharma Tech Stack
A closer look at the technologies used by Cytogel Pharma
Top Manufacturing Companies
Top companies in Canada by revenue
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Cytogel Pharma
Sign Up For FreeTo access detailed company insights
Cytogel Pharma is a clinical stage biopharmaceutical company focused on developing first-in-class drug candidates from the novel endomorphin family of peptides to provide effective pain relief. Their lead product, CYT-1010, targets key pain pathways with a unique mechanism of action, aiming to transform the treatment of moderate to severe pain whil... Read More
